Elicio Therapeutics (ELTX) Short-term Investments (2022 - 2025)

Elicio Therapeutics (ELTX) has 4 years of Short-term Investments data on file, last reported at $683000.0 in Q1 2025.

• For the quarter ending Q1 2025, Short-term Investments fell 2.43% year-over-year to $683000.0; the trailing twelve-month figure through Mar 2025 stood at $683000.0 (down 2.43% YoY), and the FY2024 full-year result was $1.2 million, up 63.16% from the prior year.
• Short-term Investments for Q1 2025 stood at $683000.0, down from $1.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.7 million in Q3 2023 and bottomed at $396000.0 in Q2 2024.
• The 4-year median for Short-term Investments is $950000.0 (2023), against an average of $1.0 million.
• The widest annual swing landed in 2023, when Short-term Investments plunged 56.0%; it then soared 63.16% in 2024.
• A 4-year view of Short-term Investments shows it stood at $1.6 million in 2022, then slumped by 56.0% to $722000.0 in 2023, then jumped by 63.16% to $1.2 million in 2024, then sank by 42.02% to $683000.0 in 2025.
• The last three Short-term Investments figures came in at $683000.0 (Q1 2025), $1.2 million (Q4 2024), and $1.3 million (Q3 2024), per Business Quant data.

Peer Comparison